









Markets
/
Stocks
/
nasdaq-ci
/

Cigna Group

291.900USD

+7.370+2.59%

Close 02/06, 16:00（ET）Quotes delayed by 15 min

76.91BMarket Cap

13.16P/E TTM



Cigna Group

291.900

+7.370+2.59%

Overview Financials Analysis Company

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

Overview

Financials

Analysis

Company

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score of Cigna Group

Currency: USD Updated: 2026-02-05

Key Insights

Cigna Group's fundamentals are relatively stable, with an industry-leading ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 5 out of 75 in the Healthcare Providers & Services industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 327.37.In the medium term, the stock price is expected to remain stable.Despite an average stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Cigna Group's Score

Industry at a Glance

Industry Ranking

5 / 75

Overall Ranking

48 / 4521

Industry

Healthcare Providers & Services

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score

Previous score

Media Coverage

Last 24 hours

Coverage Level

39°C



Very Low

Very High

Neutral

Cigna Group Highlights

StrengthsRisks

The Cigna Group is a global health company. The Company has two growth platforms: Evernorth Health Services and Cigna Healthcare. Evernorth Health Services includes its Pharmacy Benefit Services and Specialty and Care Services operating segments, which provide independent and coordinated health solutions and capabilities to enable the healthcare system to work better and help people live richer, healthier lives. Cigna Healthcare includes the U.S. Healthcare and International Health operating segments, which provide comprehensive medical plan services and coordinated solutions to clients and customers. Its Other Operations include corporate-owned life insurance (COLI), the Company's run-off operations and other non-strategic businesses. Specialty and Care Services provides specialty drugs for the treatment of complex and rare diseases, specialty distribution of pharmaceuticals and medical supplies, and clinical programs to help its clients.

Industry Leader

The company's revenue leads the industry, with the latest annual revenue totaling USD 274.90B.

High Growth

The company's revenue has grown steadily over the past 3 years, averaging 40.78% year-on-year.

High Profit Growth

The company's net income leads the industry, with the latest annual income totaling USD 274.90B.

High Dividend

The company is a high dividend payer, with the latest dividend payout ratio of 45.63%.

Stable Dividend

The company has regularly paid dividends over the past 5 years, with the latest dividend payout ratio of 45.63%.

Undervalued

The company’s latest PE is 12.83, at a low 3-year percentile range.

Institutional Buying

The latest institutional holdings are 242.25M shares, increasing 0.07% quarter-over-quarter.

Held by Barrow Hanley

Star Investor Barrow Hanley holds 13.71K shares of this stock.

Analyst Rating

Based on 25 analysts

Buy

Current Rating

327.371

Target Price

+20.56%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Financial Health

Currency: USD Updated: 2026-02-05

The current financial score of Cigna Group is 8.53, ranking 21 out of 75 in the Healthcare Providers & Services industry. Its financial status is weak, and its operating efficiency is high. Its latest quarterly revenue reached 72.47B, representing a year-over-year increase of 10.39%, while its net profit experienced a year-over-year increase of 13.34%.

Score

Industry at a Glance

Previous score

8.53

Change



Financials

5.41

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

Relevant data have not been disclosed by the company yet.



Quality of Earnings

8.89

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

Relevant data have not been disclosed by the company yet.



Operational Efficiency

8.74

Key Metrics

Cash flow from operating activities

Income after tax

Relevant data have not been disclosed by the company yet.



Growth Potential

10.00

Key Metrics

Cash flow from operating activities

Total revenue

Relevant data have not been disclosed by the company yet.



Shareholder Returns

9.63

Key Metrics

Free cash flow

Relevant data have not been disclosed by the company yet.

Cigna Group's Company Valuation

Currency: USD Updated: 2026-02-05

The current valuation score of Cigna Group is 8.47, ranking 10 out of 75 in the Healthcare Providers & Services industry. Its current P/E ratio is 12.83, which is 161.99% below the recent high of 33.61 and 14.73% above the recent low of 10.94.

Score

Industry at a Glance

Previous score

8.47

Change

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 5/75

Relevant data have not been disclosed by the company yet.

Earnings Forecast

Currency: USD Updated: 2026-02-05

The current earnings forecast score of Cigna Group is 8.16, ranking 27 out of 75 in the Healthcare Providers & Services industry. The average price target is 325.00, with a high of 378.00 and a low of 270.00.

Score

Industry at a Glance

Previous score

8.16

Change

Support & Resistance

Relevant data have not been disclosed by the company yet.

Analyst Rating

Based on 25 analysts

Buy

Current Rating

329.451

Target Price

+15.79%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

Total

Median

Average

Company name

Ratings

Analysts

Cigna Group

Unitedhealth Group Inc

UNH

Humana Inc

HUM

Elevance Health Inc

ELV

Centene Corp

CNC

Molina Healthcare Inc

MOH

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

Relevant data have not been disclosed by the company yet.

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2026-02-05

The current price momentum score of Cigna Group is 8.59, ranking 16 out of 75 in the Healthcare Providers & Services industry. Currently, the stock price is trading between the resistance level at 292.36 and the support level at 271.23, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

6.45

Change

2.14

Support & Resistance

Relevant data have not been disclosed by the company yet.

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(1)

Neutral(2)

Buy(3)

Indicators

Value

Direction

MACD(12,26,9)

0.763

Neutral

RSI(14)

58.639

Neutral

STOCH(KDJ)(9,3,3)

70.873

Buy

ATR(14)

7.353

High Vlolatility

CCI(14)

152.817

Buy

Williams %R

2.442

Overbought

TRIX(12,20)

-0.028

Sell

StochRSI(14)

100.000

Buy

Moving Average

Sell(1)

Neutral(0)

Buy(5)

Indicators

Value

Direction

MA5

275.456

Buy

MA10

275.063

Buy

MA20

275.451

Buy

MA50

274.607

Buy

MA100

280.655

Buy

MA200

294.642

Sell

Institutional Confidence

Currency: USD Updated: 2026-02-05

The current institutional shareholding score of Cigna Group is 10.00, ranking 1 out of 75 in the Healthcare Providers & Services industry. The latest institutional shareholding proportion is 91.45%, representing a quarter-over-quarter decrease of 0.49%. The largest institutional shareholder is The Vanguard, holding a total of 26.03M shares, representing 9.75% of shares outstanding, with 0.04% increase in holdings.

Score

Industry at a Glance

Previous score

10.00

Change

Institutional Shareholding

Relevant data have not been disclosed by the company yet.

Shareholder Activity

Name

Shares Held

Chg %

The Vanguard Group, Inc.

Star Investors

25.62M

+0.11%

BlackRock Institutional Trust Company, N.A.

12.64M

+1.85%

State Street Investment Management (US)

12.12M

-1.19%

MFS Investment Management

10.55M

-7.57%

T. Rowe Price Associates, Inc.

Star Investors

10.90M

+10.12%

Dodge & Cox

Star Investors

9.31M

+3.96%

Fidelity Management & Research Company LLC

8.27M

-6.12%

Sanders Capital, LLC

7.83M

+0.45%

GQG Partners, LLC

6.79M

+17.70%

Geode Capital Management, L.L.C.

6.00M

+0.67%

Risk Assessment

Currency: USD Updated: 2026-02-05

The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Healthcare Providers & Services domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of Cigna Group is 6.80, ranking 25 out of 75 in the Healthcare Providers & Services industry. The company's beta value is 0.28. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets. with an industry-leading ESG disclosure.